Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

Also called NCT01572623

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01572623
Other papers using this trial's data
  • Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study Journal of the American College of Cardiology, 2013-04-02 DOI, PubMed 23490041

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01572623. Randomized; no masking; primary purpose prevention. Start 2011-07 (registry gives no type); primary completion 2012-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting
Acronym
ARMYDA-CARO
Condition
Carotid Stenosis
Intervention (Drug)
Clopidogrel
Intervention (Drug)
Atorvastatin
Lead sponsor
Campus Bio-Medico University (class: other)

Record details

Record id
cardio:ct-nct01572623
Content hash
3d43266ea6fb737201a2acd45b4cd59dc668659fe83fb08f60752d7636ee114c